Gilead Sciences, Inc [NASDAQ: GILD] price surged by 23268120 percent to reach at $9409892.0.
A sum of 23268120 shares traded at recent session while its average daily volume was at 9.41M shares. Gilead Sciences, Inc shares reached a high of $110.16 and dropped to a low of $107.3 until finishing in the latest session at $9410000.0.
The one-year GILD stock forecast points to a potential downside of -7998879.94. The average equity rating for GILD stock is currently 1.87, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Gilead Sciences, Inc [GILD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GILD shares is $117.64 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GILD stock is a recommendation set at 1.87. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Gilead Sciences, Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on April 22, 2025. While these analysts kept the previous recommendation, Oppenheimer raised their target price from $115 to $132. The new note on the price target was released on March 04, 2025, representing the official price target for Gilead Sciences, Inc stock. Previously, the target price had yet another raise to $120, while Deutsche Bank analysts kept a Buy rating on GILD stock.
The Price to Book ratio for the last quarter was 7.05, with the Price to Cash per share for the same quarter was set at 7.34. Price to Free Cash Flow for GILD in the course of the last twelve months was 13.71 with Quick ratio for the last quarter at 1.23.
GILD Stock Performance Analysis:
Gilead Sciences, Inc [GILD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.17. With this latest performance, GILD shares dropped by -0.56% in over the last four-week period, additionally plugging by 17.87% over the last 6 months – not to mention a rise of 17.46% in the past year of trading.
Insight into Gilead Sciences, Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Gilead Sciences, Inc [GILD] shares currently have an operating margin of 38.01% and a Gross Margin at 78.25%. Gilead Sciences, Inc’s Net Margin is presently recorded at 20.79%.
Return on Equity for this stock inclined to 10.58%, with Return on Assets sitting at 10.58%.
GILD Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GILD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Gilead Sciences, Inc go to 26.05%.
Gilead Sciences, Inc [GILD] Institutonal Ownership Details
There are presently around $89.70%, or 89.81%% of GILD stock, in the hands of institutional investors. The top three institutional holders of GILD stocks are: BLACKROCK INC. with ownership of 120.63 million shares, which is approximately 9.6738%. VANGUARD GROUP INC, holding 115.26 million shares of the stock with an approximate value of $$7.91 billion in GILD stocks shares; and VANGUARD GROUP INC, currently with $$5.23 billion in GILD stock with ownership which is approximately 6.1147%.
